Publications by authors named "Sam Leo"

Claim this Profile
C
Correction: Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States.
Rakesh Jain, Rajeev Ayyagari, Debbie Goldschmidt, Mo Zhou, Stacy Finkbeiner, Sam Leo

J Patient Rep Outcomes· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States.
Rakesh Jain, Rajeev Ayyagari, Debbie Goldschmidt, Mo Zhou, Stacy Finkbeiner, Sam Leo

J Patient Rep Outcomes· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia.
Daniel O Claassen, Rajeev Ayyagari, Viviana García-Horton, Su Zhang, Sam Leo

Ment Health Clin· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Tardive Dyskinesia on Physical, Psychological, Social, and Professional Domains of Patient Lives: A Survey of Patients in the United States.
Rakesh Jain, Rajeev Ayyagari, Debbie Goldschmidt, Mo Zhou, Stacy Finkbeiner, Sam Leo

J Clin Psychiatry· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.
Daniel O Claassen, Rajeev Ayyagari, Debbie Goldschmidt, Mo Zhou, Sam Leo

Adv Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease: A Retrospective Database Analysis.
Daniel O Claassen, Rajeev Ayyagari, Viviana Garcia-Horton, Su Zhang, Jessica Alexander, Sam Leo

Neurol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining utility values for patients with tardive dyskinesia.
Rajeev Ayyagari, Debbie Goldschmidt, Mo Zhou, Rinat Ribalov, Stanley N Caroff, Sam Leo

Curr Med Res Opin· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113.
Weiguang Xue, Rinat Ribalov, Zheng-Yi Zhou, Rajeev Ayyagari, Sam Leo

J Med Econ· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Antipsychotic Dose Reduction on Clinical Outcomes and Health Care Resource Use Among Medicare Patients with Schizophrenia.
Miriam L Zichlin, Fan Mu, Sam Leo, Rajeev Ayyagari

Clin Drug Investig· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis